Prostate Specific Antigen (PSA) Test Market Overall Study Report 2023-2032 | Siemens AG, F. Hoffmann-La Roche AG, Bayer AG, Abbott Laboratories, Becton Dickinson and Company

The Prostate Specific Antigen (PSA) Test Global Market Report 2023, provides comprehensive information on the prostate specific antigen (PSA) test market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.

Learn More On The Prostate Specific Antigen (PSA) Test Market’s Growth:

https://thebusinessresearchcompany.com/report/prostate-specific-antigen-psa-test-global-market-report

As per The Business Research Company’s Prostate Specific Antigen (PSA) Test Global Market Report 2023, the global prostate-specific antigen (PSA) test market is expected to grow from $3.24 billion in 2022 to $3.66 billion in 2023 at a compound annual growth rate (CAGR) of 13.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and resulted in increased interest rates affecting many markets across the globe. The prostate-specific antigen (PSA) test market is expected to reach $5.73 billion in 2027 at a CAGR of 11.8%.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample_request?id=12576&type=smp

Technological advancements are the key trend gaining popularity in the prostate-specific antigen (PSA) test market. Major companies operating in the prostate-specific antigen (PSA) test market are developing advanced screening test tools to sustain their position in the market. For instance, in February 2023, LynxDx Inc., a US-based diagnostic company, launched MyProstateScore 2.0, a non-invasive urine prostate cancer screening test. This innovative test uses a combination of 18 biomarkers, including the novel gene fusion T2:ERG, to provide a personalized risk assessment for each patient. Additionally, this screening test offers highly accurate, stratified risk assessment insights to guide clinical decisions for patients with elevated prostate-specific antigen (PSA) or abnormal digital rectal exam (DRE) findings. Moreover, it has the potential to improve prostate cancer screening and treatment.

The prostate specific antigen (PSA) test market is segmented:

1) By Type: Clinical Laboratory Improvement Amendments (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA), Fluorescence Immunoassay (FIA), Other Types

2) By Application: Screening, Post-Treatment Monitoring, Other Applications

3) By End User: Hospitals, Diagnostic Centers, Research Institutes, Other End Users

North America was the largest region in the prostate specific antigen (PSA) test market in 2022.

The table of contents in TBRC’s prostate specific antigen (PSA) test market report includes:

1. Executive Summary

2. Prostate Specific Antigen (PSA) Test Market Characteristics

3. Prostate Specific Antigen (PSA) Test Market Trends And Strategies

4. Prostate Specific Antigen (PSA) Test Market – Macro Economic Scenario

5. Global Prostate Specific Antigen (PSA) Test Market Size and Growth

…

32. Global Prostate Specific Antigen (PSA) Test Market Competitive Benchmarking

33. Global Prostate Specific Antigen (PSA) Test Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Prostate Specific Antigen (PSA) Test Market

35. Prostate Specific Antigen (PSA) Test Market Future Outlook and Potential Analysis

Learn About Us:

The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model